Australian Capital Territory
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2010 (No 1)
Subordinate Law SL2010-1

The Australian Capital Territory Executive makes the following regulation under the Medicines, Poisons and Therapeutic Goods Act 2008.
Dated 6 January 2010
Katy Gallagher
Minister
Simon Corbell
Minister

Australian Capital Territory
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2010 (No 1)
Subordinate Law SL2010-1
made under the
Medicines, Poisons and Therapeutic Goods Act 2008

    
    
Contents
	Page

	1	Name of regulation	1
	2	Commencement	1
	3	Legislation amended	1
	4	Section 41 (3), definition of relevant approval particulars, paragraph (a) (ii)	1
	5	Section 557 heading	1
	6	Section 557 (2) (a) and (b)	2
	7	Section 563 (c) (i) to (iii), except note	2

1	Name of regulation
This regulation is the Medicines, Poisons and Therapeutic Goods Amendment Regulation 2010 (No 1).
2	Commencement
This regulation commences on the day after its notification day.
Note	The naming and commencement provisions automatically commence on the notification day (see Legislation Act, s 75 (1)).
3	Legislation amended
This regulation amends the Medicines, Poisons and Therapeutic Goods Regulation 2008.
4	Section 41 (3), definition of relevant approval particulars, paragraph (a) (ii)
omit
Standing approval
substitute
Standing interim approval
5	Section 557 heading
substitute
557	Standing interim approval to prescribe buprenorphine and methadone for patients of certain institutions
6	Section 557 (2) (a) and (b)
substitute
	(a)	the doctor—
	(i)	is working at a hospital and prescribes the medicine for an outpatient at the hospital; or
	(ii)	is working at any of the following institutions and prescribes the medicine for a patient of the institution:
	(A)	a correctional centre;
	(B)	a CYP detention place;
	(C)	an opioid dependency treatment centre operated by the Territory; or
Note	Institution includes a correctional centre and a CYP detention place (see s 652).
	(iii)	prescribes the medicine for a person in police custody; and
7	Section 563 (c) (i) to (iii), except note
substitute
	(i)	a doctor who is working at a hospital, or an institution mentioned in section 557 (2) (a) (ii) (Standing interim approval to prescribe buprenorphine and methadone for patients of certain institutions); or
	(ii)	an intern doctor who is working at a hospital, or an institution mentioned in section 557 (2) (a) (ii), and who is acting under the direct supervision of a doctor at the hospital or institution; or
	(iii)	a doctor who is treating a person held in police custody; or
	(iv)	a doctor who holds an endorsement under section 582 (CHO decisions on applications for endorsement to treat drug‑dependency); or
	(v)	a doctor who is prescribing continuing opioid dependency treatment for up to 5 drug-dependent people if—
	(A)	the people have already undergone opioid dependency treatment for at least 14 consecutive days (the initial treatment); and
	(B)	the initial treatment was prescribed by a doctor holding an endorsement under section 582.

Endnotes
1	Notification
	Notified under the Legislation Act on 21 January 2010.
2	Republications of amended laws
	For the latest republication of amended laws, see www.legislation.act.gov.au.

© Australian Capital Territory 2010